Parent Terms |
Term With Siblings |
Child Terms |
|
2-deoxy-2-((18)F)fluoro-D-glucose +
flotufolastat F-18 gallium An (18)F radiopharmaceutical which is used as a radioactive diagnostic agent for positron emission tomography (PET) of prostate-specific membrane antigen positive lesions in men with prostate cancer.
|
|
 |
Synonyms |
Exact Synonyms: |
gallium hydrogen (3S,7S,12R,26R)-26-{[N-{(4S)-4-carboxylato-4-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetraazacyclododecan-1-yl]butanoyl}-3-(4-{di-tert-butyl[((18)F)fluoro]silyl}benzamido)-D-alanyl]amino}-5,10,17,20-tetraoxo-4,6,11,16,21-pentaazahexacosane-1,3,7,12,26-pentacarboxylate (1:6:1)
|
Related Synonyms: |
Formula=C63H90[18F]N12O25Si.Ga.H.H.H.H.H.H
;
InChI=1S/C63H99FN12O25Si.Ga/c1-62(2,3)102(64,63(4,5)6)39-14-12-38(13-15-39)54(89)67-34-44(69-49(80)20-18-45(60(99)100)76-32-30-74(36-52(85)86)28-26-73(35-51(83)84)27-29-75(31-33-76)37-53(87)88)55(90)70-41(57(93)94)10-7-8-24-65-46(77)21-22-47(78)66-25-9-11-40(56(91)92)68-48(79)19-16-42(58(95)96)71-61(101)72-43(59(97)98)17-23-50(81)82;/h12-15,40-45H,7-11,16-37H2,1-6H3,(H,65,77)(H,66,78)(H,67,89)(H,68,79)(H,69,80)(H,70,90)(H,81,82)(H,83,84)(H,85,86)(H,87,88)(H,91,92)(H,93,94)(H,95,96)(H,97,98)(H,99,100)(H2,71,72,101);/q;+3/p-3/t40-,41-,42+,43+,44-,45+;/m1./s1/i64-1;
;
InChIKey=OJPQWJNFDOFXTN-WRFPGERRSA-K
;
Posluma
;
SMILES=[H+].[H+].[H+].[H+].[H+].[H+].[Ga+3].CC(C)(C)[Si]([18F])(C1=CC=C(C=C1)C(=O)NC[C@@H](NC(=O)CC[C@H](N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1)C([O-])=O)C(=O)N[C@H](CCCCNC(=O)CCC(=O)NCCC[C@@H](NC(=O)CC[C@H](NC(=O)N[C@@H](CCC([O-])=O)C([O-])=O)C([O-])=O)C([O-])=O)C([O-])=O)C(C)(C)C
;
flotufolastat F18 gallium
|
Xrefs: |
CAS:2305081-64-3
;
KEGG:D12606
;
PMID:37439946 |
|